tiprankstipranks
Advertisement
Advertisement

IBIO Stock Latest News

iBio Updates Governance Deadlines for 2026 Annual Meeting
Company AnnouncementsiBio Updates Governance Deadlines for 2026 Annual Meeting
4d ago
8K
IBIO
Buy Rating Reiterated on iBio as IBIO-610 Data Underscore Differentiated Efficacy; $5 Price Target Maintained
PremiumRatings
Buy Rating Reiterated on iBio as IBIO-610 Data Underscore Differentiated Efficacy; $5 Price Target Maintained
21d ago
IBIO
iBio Highlights Promising New Preclinical Obesity Antibody Data
PremiumCompany Announcements
iBio Highlights Promising New Preclinical Obesity Antibody Data
21d ago
8K
IBIO
iBio announces new preclinical data from IBIO-610 study
PremiumThe Fly
iBio announces new preclinical data from IBIO-610 study
21d ago
IBIO
iBio initiated with an Outperform at Raymond James
PremiumThe Fly
iBio initiated with an Outperform at Raymond James
1M ago
IBIO
iBio doses first participant in IBIO-600 trial
PremiumThe FlyiBio doses first participant in IBIO-600 trial
2M ago
IBIO
IBIO-600 First-in-Human Obesity Trial Puts iBio on Investors’ Radar
Premium
Company Announcements
IBIO-600 First-in-Human Obesity Trial Puts iBio on Investors’ Radar
2M ago
IBIO
iBio reports Q3 EPS (7c), consensus (6c)
Premium
The Fly
iBio reports Q3 EPS (7c), consensus (6c)
2M ago
IBIO
iBio Strengthens Board with Appointment of Dr. Stoner
PremiumCompany Announcements
iBio Strengthens Board with Appointment of Dr. Stoner
2M ago
8K
IBIO
Validating iBio’s Antibody Platform: Buy Rating Driven by IBIO-600’s Differentiated Obesity Profile and Long-Acting Myostatin Inhibition
PremiumRatings
Validating iBio’s Antibody Platform: Buy Rating Driven by IBIO-600’s Differentiated Obesity Profile and Long-Acting Myostatin Inhibition
3M ago
IBIO
iBio Advances to Clinical Stage With IBIO-600 Trial
PremiumCompany Announcements
iBio Advances to Clinical Stage With IBIO-600 Trial
3M ago
8K
IBIO
iBio receives regulatory clearance to initiate IBIO-600 trial in Australia
PremiumThe Fly
iBio receives regulatory clearance to initiate IBIO-600 trial in Australia
3M ago
IBIO
Biotech Alert: Searches spiking for these stocks today
PremiumThe FlyBiotech Alert: Searches spiking for these stocks today
4M ago
ACOG
IBIO
Insiders Rock Asana, Ibio, Redwire, AFLAC, Sibanye Stillwater
Premium
Weekend Updates
Insiders Rock Asana, Ibio, Redwire, AFLAC, Sibanye Stillwater
4M ago
AFL
RDW
iBio (IBIO-610): Validated Activin E Mechanism, Strategic Trial Positioning, and Attractive Risk-Reward Support a Buy Rating
Premium
Ratings
iBio (IBIO-610): Validated Activin E Mechanism, Strategic Trial Positioning, and Attractive Risk-Reward Support a Buy Rating
4M ago
IBIO
Buy Rating on iBio Driven by Differentiated Activin-Targeting Antibody and Large PH-HFpEF Market Opportunity
PremiumRatings
Buy Rating on iBio Driven by Differentiated Activin-Targeting Antibody and Large PH-HFpEF Market Opportunity
4M ago
IBIO
iBio to provide update on cardiopulmonary program
PremiumThe Fly
iBio to provide update on cardiopulmonary program
4M ago
IBIO
Buy Rating on iBio Driven by Promising IBIO-610 Obesity Data and Favorable Risk-Reward Profile
PremiumRatings
Buy Rating on iBio Driven by Promising IBIO-610 Obesity Data and Favorable Risk-Reward Profile
4M ago
IBIO
iBio Highlights IBIO-610 Obesity and Cardiometabolic Potential
PremiumCompany Announcements
iBio Highlights IBIO-610 Obesity and Cardiometabolic Potential
4M ago
8K
IBIO
iBio announces new preclinical data from study evaluating IBIO-610
PremiumThe FlyiBio announces new preclinical data from study evaluating IBIO-610
4M ago
IBIO
iBio initiated with a Buy at JonesResearch
Premium
The Fly
iBio initiated with a Buy at JonesResearch
5M ago
IBIO
Ibio Ends At-The-Market Equity Offering Program
Premium
Company Announcements
Ibio Ends At-The-Market Equity Offering Program
5M ago
8K
IBIO

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >